G.C. Chemie Pharmie Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 23-01-2025
- Paid Up Capital ₹ 1.11 Cr
as on 23-01-2025
- Company Age 29 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 87.82 Cr
as on 23-01-2025
- Satisfied Charges ₹ 26.66 Cr
as on 23-01-2025
About G.C. Chemie Pharmie
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.11 Cr.
The company currently has active open charges totaling ₹87.82 Cr. The company has closed loans amounting to ₹26.66 Cr, as per Ministry of Corporate Affairs (MCA) records.
Umesh Mehta, Jaydeep Mehta, Gautam Shah, and Three other members serve as directors at the Company.
- CIN/LLPIN
U51900MH1995PLC088175
- Company No.
088175
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 May 1995
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does G.C. Chemie Pharmie Limited offer?
G.C. Chemie Pharmie Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Chemical Reagents & Catalysts, Ammonium Compound, Pharmaceutical Excipients, Non-Enteric Tablet Coating, Vitamin Powder API, Ferric Ammonium Citrate Powder API, API (Active Pharmaceutical Ingredients), Hormones and Steroid API.
Who are the key members and board of directors at G.C. Chemie Pharmie?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gautam Shah  | Managing Director | 08-May-1995 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Mehta  | Director | 31-Aug-2023 | Current |
| Jaydeep Mehta | Director | 08-Nov-2016 | Current |
| Sonal Shah | Director | 08-May-1995 | Current |
| Manitt Shah | Director | 11-Apr-2022 | Current |
| Dhrumill Shah | Director | 11-Apr-2022 | Current |
Financial Performance of G.C. Chemie Pharmie.
G.C. Chemie Pharmie Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of G.C. Chemie Pharmie?
In 2024, G.C. Chemie Pharmie had a promoter holding of 99.43% and a public holding of 0.57%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Novo Excipients Private LimitedActive 21 years 3 monthsGautam Shah and Sonal Shah are mutual person
Charges (Loans)
₹87.82 Cr
₹26.66 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 30.00 Cr
- Others : 28.66 Cr
- Icici Bank Limited : 25.41 Cr
- 3I Infotech Trusteeship Services Limited : 3.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Feb 2018 | Yes Bank Limited | ₹30.00 Cr | Open |
| 27 Jul 2017 | Others | ₹28.66 Cr | Open |
| 09 Sep 2011 | Icici Bank Limited | ₹3.00 Cr | Open |
| 17 Aug 2010 | Icici Bank Limited | ₹4.41 Cr | Open |
| 24 Apr 2008 | 3I Infotech Trusteeship Services Limited | ₹3.75 Cr | Open |
How Many Employees Work at G.C. Chemie Pharmie?
G.C. Chemie Pharmie has a workforce of 91 employees as of Jan 23, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G.C. Chemie Pharmie, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G.C. Chemie Pharmie's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
